Tech Company Financing Transactions
Svelte Medical Systems Funding Round
West Health Investment Fund participated in a $5 million funding round for Svelte Medical Systems. The funding round was announced on 3/10/2014.
Transaction Overview
Company Name
Announced On
3/10/2014
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds will be used to accelerate regulatory approval processes in the US and Japan, enhance operational efficiencies and augment commercial preparation activities of the Svelte drug-eluting coronary stent Integrated Delivery System (IDS) and Rapid-Exchange (RX) platforms.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
675 Central Ave.
New Providence, NJ 07974
USA
New Providence, NJ 07974
USA
Phone
Website
Email Address
Overview
Svelte Medical Systems, Inc. (Svelte) is a privately held company focused on delivering novel products in the $5 billion coronary stent market. Svelte has a mission to address key clinical issues in the stent market by improving stent deliverability, reducing cost and dramatically improving the safety of the device compared to currently market products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jack Darby
VP - Operations
Keith Roberts
VP - R & D
Diana Williamson
VP - Regulatory Affairs
Mark Kielek
VP - Sales
Richard Spencer
Browse more venture capital transactions:
Prev: 3/10/2014: Knowledge Delivery Systems venture capital transaction
Next: 3/11/2014: vIPtela venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on funding rounds that are announced publicly. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs